Advertisement

Topics

Valeant-Takeda Talks Said off

05:44 EST 1 Dec 2016 | CHEManager

Talks between Valeant and Takeda about a takeover of Valeant’s Salix subsidiary for $10 billion have broken down amid disagreements over price, among other things, according to the US business newspaper Wall Street Journal (WSJ).  The paper initially broke the news about talks between the Canada-headquartered, US managed drugmaker and the Japanese pharmaceutical producer.

Original Article: Valeant-Takeda Talks Said off

NEXT ARTICLE

More From BioPortfolio on "Valeant-Takeda Talks Said off"

Quick Search
Advertisement